GHCL: Another Hostile Takeover Brewing

Published on Thu, Aug 28, 2008 at 18:33 |  Source : CNBC-TV18

Updated at Thu, Aug 28, 2008 at 18:35  

4086 Investors following Guj Heavy Chem. Share this News with them.
0
0
Share on Tumblr

CNBC-TV18s Research Analyst, Raja Rajeshwari : This could be history in making for corporate India. In yet another twist to GHCL story, some shareholders are seeking replacement of Mr Sanjay Dalmia, Chairman of GHCL as Director of the company. GHCL received Sec 257 notice to challenge the directorship of Sanjay Dalmia, P K Laheri & G C Srivastava from Mr K K Rao, Mr K K Khadaria & Mr Pradeep Dixit as director of the company.

This clearly is an attempt to make a hostile takeover by thwarting Mr Sanjay Dalmia from day-to-day operations of GHCL.

As CNBC-TV18 was first to report that promoters are facing problems from every angle. Promoters stake came down from 47% to 40% in last quarter, company's stake sale plan with Al Rostamani has likely fallen off, informed investors have been accumulating stake in the company at lower levels, several high net worth investors holding GHCL stock have been approached for proxy ahead of AGM and reports of family feud have been circulating in the press.

All this indicates that informed people are building up their position and getting ready for big day i.e GHCL AGM on Sep 12 where in it will be ultimately decided that whether Mr Sanjay Dalmia will continue as director or not. It will not be less than any assembely where in the voting rights will ultimately decide future of Mr Sanjay Dalmia.

  

Trending News

Business News

Pre-book the Samsung Galaxy S III on Snapdeal for Rs. 250
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

GoM On Coal Gives Conditional Nod To Chatrasal Coal Block

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!